Table 2.
NCAM2 interactions and post-translational modifications.
| Extracellular Region | |
|---|---|
| Interaction | References |
| Fibroblast Growth Factor Receptor (FGFR) | [80] |
| Epidermal Growth Factor Receptor (EGFR) | [79] |
| Nogo | [70] |
| Granulin | [70] |
| Prion protein (Prp) | [81,82] |
| Beta-site APP cleaving enzyme 1 (BACE1) | [75] |
| Post-translational modification | |
| N-glycosylation | [78] |
| Proteolytic cleavage | [75,76] |
| Intracellular region | |
| Interaction | References |
| Proto-oncogene tyrosine-protein kinase Src | [83] |
| Calcium/calmodulin-dependent protein kinase type II (CaMKII) | [69,83] |
| Microtubule-associated protein 2 (MAP2) | [69] |
| Actin | [70] |
| Tubulin | [69] |
| 14-3-3 family proteins | [69,81,82] |
| Microtubule-associated protein 1B (MAP1B) | [70] |
| F-actin-capping complex (CAPZ) | [70] |
| Heat shock cognate 71 protein (HSC70) | [70] |
| Postranslational modification | |
| Palmitoylation | [70,74] |
| Phosphorylation | [73] |